JAG Team Insights — Obesity Drug Craze Approaching Critical Milestone

Graphic chart showing disrupting disease progression in diabetes and obesity to improve outcomes

June 2023 In recent years, a class of drugs known as GLP-1 agonists have experienced an unprecedented rise in popularity and captured the attention of doctors, patients, and investors alike. GLP-1 is short for glucagon-like peptide 1, a natural hormone produced by the human body which the drugs are designed to mimic. For the general […]

JAG Team Insights — The AI Revolution: Framing Risks and Opportunities

April 4, 2023 Over the past several months, Artificial Intelligence (AI) has leaped from the realm of science fiction into reality right before our eyes. The evolution has taken decades, but the impressive growth in power and user access has accelerated very recently with ChatGPT. This process continues to evolve extremely rapidly, in raw technology, […]

JAG Team Insights — The Debt Ceiling Debate & Financial Market Impacts

February 17, 2023 Raising the debt ceiling is a regular feature of the US political and financial landscape. Since June 1942 the Federal borrowing limit has been raised or suspended a total of 93 times. The US government hit the statutory debt ceiling on January 19, 2023, which has prompted debate over what will ultimately […]

JAG Team Insights — Putting Recent Tech Layoffs into Context

January 27, 2023 Almost every day we have been hearing the news of tech layoffs, most recently Alphabet (Google) and Spotify each announcing a 6% workforce reduction. While layoffs often point towards a weakening economy, we believe these headcount reductions primarily reflect idiosyncratic factors in the tech industry and have a relatively limited read-through for […]

JAG Team Insights — An Electric Opportunity: Renewable Energy Generation

December 15, 2022 The US and much of the world is engaged in a multi-decade effort to replace fossil fuels with renewable, non-CO2 emitting sources of energy. This is an enormous project that will require vast amounts of capital to implement. JAG believes the adoption of the new technologies involved in this transition has and […]

JAG Team Insights: What’s Next for Health Care Investors?

August 22, 2022 The Inflation Reduction Act has major implications for many investment sectors, including Health Care. This Insight focuses on the powers granted by the Act to Medicare to negotiate drug prices over a multi-year path. The effects will not be felt evenly across the industry. Drug companies with the forethought to have built […]

JAG Team Insights: Electric Opportunity – Upgrading the Grid

June 24, 2022 Reliable, affordable electrical power is a key requirement for US businesses to compete effectively in a global economy and a necessity for consumers. Meanwhile, there is growing consensus among global policymakers, corporations, and investors that supports transitioning to clean and renewable sources of energy. The US has committed to a multi-year program […]

JAG Team Insights: Assessing High Gas Prices and Shortage Risks

May 24, 2022 —  Summary A confluence of factors including the recovery of demand, capacity reductions, lower China exports, and geopolitical tensions are driving record-high gasoline and diesel prices. Clean petroleum product (such as gasoline, diesel, jet fuel) inventories remain low globally, with some countries already experiencing product shortages. While supply shortage risks also exist […]

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

eMoney

eMoney is an industry-leading financial planning platform designed to help advisors, planners, and RIAs deliver personalized, comprehensive financial advice to clients across all stages of life.

Nitrogen

Nitrogen is a client-engagement and advisor platform built to bring clarity, quantification, and alignment to risk tolerance and portfolio construction. It uses a proprietary system that simplifies risk into a single, objective metric — the Risk Number® — allowing advisors and clients to speak the same language about risk, rather than relying on vague, subjective labels like “moderate” or “aggressive.”

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

You are now leaving

www.jagcap.com